Drugs / FNP-59
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04546126 | Nov 2021 → Dec 2026 expected | hypertensive disorder | Benjamin Viglianti | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FNP-59 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04546126 ↗ |
| Modality | Diagnostic / imaging agent | “FNP-59, a radiotracer, is administered for PET/CT scans.” NCT04546126 ↗ |